Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/33983
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | NYITRAY, Alan G. | - |
dc.contributor.author | PENG, Fen | - |
dc.contributor.author | DAY, Rena S. | - |
dc.contributor.author | SILVA, Roberto J. Carvalho Da | - |
dc.contributor.author | BAGGIO, Maria Luiza | - |
dc.contributor.author | SALMERON, Jorge | - |
dc.contributor.author | QUITERIO, Manuel | - |
dc.contributor.author | ABRAHAMSEN, Martha | - |
dc.contributor.author | LAZCANO-PONCE, Eduardo | - |
dc.contributor.author | VILLA, Luisa L. | - |
dc.contributor.author | GIULIANO, Anna R. | - |
dc.date.accessioned | 2019-11-06T18:46:41Z | - |
dc.date.available | 2019-11-06T18:46:41Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | HUMAN VACCINES & IMMUNOTHERAPEUTICS, v.15, n.7-8, Special Issue, p.1911-1919, 2019 | - |
dc.identifier.issn | 2164-5515 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/33983 | - |
dc.description.abstract | Background: While receptive anal sex is an established risk factor for anal human papillomavirus (HPV) infection and squamous cell carcinoma of the anus (SCCA), people with anal HPV infection and SCCA commonly report no lifetime receptive anal sex suggesting other factors may also increase risk for anal HPV infection and persistence. Given potential associations between obesity and conditions that may cause perianal or anal canal lesions, we hypothesized that body mass index (BMI) was associated with HPV infection.Methods: Genotyping for 36 HPV types was conducted on anal canal specimens from men, ages 18-70, from Brazil, Mexico, and the USA. Eligibility included no history of genital warts or HIV. Evaluable specimens were collected from 328 men having sex with men (MSM) and 1348 men having sex with women (MSW) who reported no lifetime receptive anal sex. Prevalence of anal HPV infection and six-month persistence by BMI were estimated in addition to adjusted prevalence ratios for the association between BMI and HPV infection.Results: Among MSW, obese men had a higher prevalence of HPV-16 in the anal canal (3.1%), compared to normal weight men (1.3%) although 95% CI overlapped. Among MSM, prevalence of HPV decreased with increasing BMI. A similar pattern was observed for persistence. After adjustment for confounders, obese MSW had 2.4 times higher odds of HPV-16 compared to normal weight men.Conclusions: BMI may be positively associated with anal HPV (especially HPV-16) among MSW and negatively associated with anal HPV among MSM which supports continued universal HPV vaccination programs. | eng |
dc.description.sponsorship | National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [5R21AI101417-3] | - |
dc.description.sponsorship | National Cancer Institute (NCI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [NIH RO1 CA098803 01-A1] | - |
dc.language.iso | eng | - |
dc.publisher | TAYLOR & FRANCIS INC | eng |
dc.relation.ispartof | Human Vaccines & Immunotherapeutics | - |
dc.rights | restrictedAccess | eng |
dc.subject | HPV | eng |
dc.subject | men | eng |
dc.subject | persistence | eng |
dc.subject | epidemiology | eng |
dc.subject | BMI | eng |
dc.subject | heterosexual men | eng |
dc.subject.other | inflammatory-bowel-disease | eng |
dc.subject.other | risk-factors | eng |
dc.subject.other | sexual practices | eng |
dc.subject.other | cancer | eng |
dc.subject.other | infection | eng |
dc.subject.other | men | eng |
dc.subject.other | hpv | eng |
dc.subject.other | health | eng |
dc.subject.other | trends | eng |
dc.subject.other | women | eng |
dc.title | The association between body mass index and anal canal human papillomavirus prevalence and persistence: the HIM study | eng |
dc.type | article | eng |
dc.rights.holder | Copyright TAYLOR & FRANCIS INC | eng |
dc.identifier.doi | 10.1080/21645515.2019.1593083 | - |
dc.identifier.pmid | 30897017 | - |
dc.subject.wos | Biotechnology & Applied Microbiology | eng |
dc.subject.wos | Immunology | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
hcfmusp.author.external | NYITRAY, Alan G.:Med Coll Wisconsin, Ctr Clin Canc, 2071 North Summit Ave, Milwaukee, WI 53202 USA; Med Coll Wisconsin, Ctr AIDS Intervent Res, 2071 North Summit Ave, Milwaukee, WI 53202 USA | - |
hcfmusp.author.external | PENG, Fen:Medtronic Inc, Dept Clin Res, Northridge, CA USA | - |
hcfmusp.author.external | DAY, Rena S.:Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA | - |
hcfmusp.author.external | SILVA, Roberto J. Carvalho Da:Ctr Referencia & Treinamento DST AIDS, Dept STDs, Sao Paulo, Brazil | - |
hcfmusp.author.external | SALMERON, Jorge:Univ Nacl Autonoma Mexico, Rese Ctr Policies Populat & Hlth, Fac Med, Mexico City, DF, Mexico; Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico | - |
hcfmusp.author.external | QUITERIO, Manuel:Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico | - |
hcfmusp.author.external | ABRAHAMSEN, Martha:H Lee Moffitt Canc Ctr & Res Inst, Ctr Immunizat & Infect Res Canc, Tampa, FL USA | - |
hcfmusp.author.external | LAZCANO-PONCE, Eduardo:Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico | - |
hcfmusp.author.external | GIULIANO, Anna R.:H Lee Moffitt Canc Ctr & Res Inst, Ctr Immunizat & Infect Res Canc, Tampa, FL USA | - |
hcfmusp.description.beginpage | 1911 | - |
hcfmusp.description.endpage | 1919 | - |
hcfmusp.description.issue | 7-8 | - |
hcfmusp.description.issue | Special Issue | - |
hcfmusp.description.volume | 15 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | WOS:000482271400060 | - |
hcfmusp.origem.id | 2-s2.0-85064652852 | - |
hcfmusp.publisher.city | PHILADELPHIA | eng |
hcfmusp.publisher.country | USA | eng |
hcfmusp.relation.reference | BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173 | eng |
hcfmusp.relation.reference | Beaugerie L, 2018, CLIN GASTROENTEROL H, V16, P892, DOI 10.1016/j.cgh.2017.11.041 | eng |
hcfmusp.relation.reference | Beck D, 2009, ASCRS MANUAL COLON R, P259 | eng |
hcfmusp.relation.reference | Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8 | eng |
hcfmusp.relation.reference | Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1705 | eng |
hcfmusp.relation.reference | Chaturvedi AK, 2010, J ADOLESCENT HEALTH, V46, pS20, DOI 10.1016/j.jadohealth.2010.01.016 | eng |
hcfmusp.relation.reference | Chiao EY, 2005, JAIDS-J ACQ IMM DEF, V40, P451, DOI 10.1097/01.qai.0000159669.80207.12 | eng |
hcfmusp.relation.reference | Chutkan R, 2012, J AM ACAD NURSE PRAC, V24, P476, DOI 10.1111/j.1745-7599.2012.00758.x | eng |
hcfmusp.relation.reference | Cress RD, 2003, PREV MED, V36, P555, DOI 10.1016/S0091-7435(03)00013-6 | eng |
hcfmusp.relation.reference | Daling JR, 2004, CANCER, V101, P270, DOI 10.1002/cncr.20365 | eng |
hcfmusp.relation.reference | DALING JR, 1987, NEW ENGL J MED, V317, P973, DOI 10.1056/NEJM198710153171601 | eng |
hcfmusp.relation.reference | Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083 | eng |
hcfmusp.relation.reference | Frisch M, 1998, BRIT J CANCER, V78, P1534, DOI 10.1038/bjc.1998.719 | eng |
hcfmusp.relation.reference | Frisch M, 1997, NEW ENGL J MED, V337, P1350, DOI 10.1056/NEJM199711063371904 | eng |
hcfmusp.relation.reference | Garland SM, 2016, CLIN INFECT DIS, V63, P519, DOI 10.1093/cid/ciw354 | eng |
hcfmusp.relation.reference | Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151 | eng |
hcfmusp.relation.reference | Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2 | eng |
hcfmusp.relation.reference | Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020 | eng |
hcfmusp.relation.reference | Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357 | eng |
hcfmusp.relation.reference | Halperin DT, 1999, AIDS PATIENT CARE ST, V13, P717, DOI 10.1089/apc.1999.13.717 | eng |
hcfmusp.relation.reference | Hanauer SB, 2001, AM J GASTROENTEROL, V96, P635 | eng |
hcfmusp.relation.reference | Hernandez BY, 2005, CANCER EPIDEM BIOMAR, V14, P2550, DOI 10.1158/1055-9965.EPI-05-0460 | eng |
hcfmusp.relation.reference | HOLLY EA, 1989, JNCI-J NATL CANCER I, V81, P1726, DOI 10.1093/jnci/81.22.1726 | eng |
hcfmusp.relation.reference | HOLMES F, 1988, GASTROENTEROLOGY, V95, P107, DOI 10.1016/0016-5085(88)90297-1 | eng |
hcfmusp.relation.reference | Islami F, 2017, INT J EPIDEMIOL, V46, P924, DOI 10.1093/ije/dyw276 | eng |
hcfmusp.relation.reference | JENSEN SL, 1988, DIS COLON RECTUM, V31, P770, DOI 10.1007/BF02560104 | eng |
hcfmusp.relation.reference | Kreuter R, 2019, BBA-MOL BASIS DIS, V1865, P63, DOI 10.1016/j.bbadis.2018.10.020 | eng |
hcfmusp.relation.reference | Lin CQ, 2018, LANCET INFECT DIS, V18, P198, DOI [10.1016/s1473-3099(17)30653-9, 10.1016/S1473-3099(17)30653-9] | eng |
hcfmusp.relation.reference | Liu G, 2015, SEX TRANSM DIS, V42, P20, DOI 10.1097/OLQ.0000000000000231 | eng |
hcfmusp.relation.reference | Madalinski Mariusz H, 2011, World J Gastrointest Pharmacol Ther, V2, P9, DOI 10.4292/wjgpt.v2.i2.9 | eng |
hcfmusp.relation.reference | Markland AD, 2013, AM J GASTROENTEROL, V108, P796, DOI 10.1038/ajg.2013.73 | eng |
hcfmusp.relation.reference | Nyitray A, 2008, J INFECT DIS, V197, P1676, DOI 10.1086/588145 | eng |
hcfmusp.relation.reference | Nyitray AG, 2016, CLIN INFECT DIS, V62, P1367, DOI 10.1093/cid/ciw140 | eng |
hcfmusp.relation.reference | Nyitray AG, 2011, J INFECT DIS, V204, P1711, DOI 10.1093/infdis/jir637 | eng |
hcfmusp.relation.reference | Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021 | eng |
hcfmusp.relation.reference | Nyitray AG, 2010, J INFECT DIS, V201, P1498, DOI 10.1086/652187 | eng |
hcfmusp.relation.reference | Nyitray AG, 2009, AM J EPIDEMIOL, V170, P965, DOI 10.1093/aje/kwp225 | eng |
hcfmusp.relation.reference | Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300 | eng |
hcfmusp.relation.reference | Piketty C, 2003, ANN INTERN MED, V138, P453, DOI 10.7326/0003-4819-138-6-200303180-00008 | eng |
hcfmusp.relation.reference | Proctor Robert N, 2004, Clin Lung Cancer, V5, P371, DOI 10.3816/CLC.2004.n.016 | eng |
hcfmusp.relation.reference | Quan S, 2011, GASTROENTEROLOGY, V140, pS730 | eng |
hcfmusp.relation.reference | Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598 | eng |
hcfmusp.relation.reference | Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87 | eng |
hcfmusp.relation.reference | Ruel J, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.8 | eng |
hcfmusp.relation.reference | Savin-Williams RC, 2007, ARCH SEX BEHAV, V36, P385, DOI 10.1007/s10508-006-9088-5 | eng |
hcfmusp.relation.reference | Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108 | eng |
hcfmusp.relation.reference | Shah SB, 2015, CLIN GASTROENTEROL H, V13, P1955, DOI 10.1016/j.cgh.2015.05.031 | eng |
hcfmusp.relation.reference | Slesser AAP, 2013, SURG ONCOL, V22, P230, DOI 10.1016/j.suronc.2013.08.002 | eng |
hcfmusp.relation.reference | Steele SR, 2006, ALIMENT PHARM THERAP, V24, P247, DOI 10.1111/j.1365-2036.2006.02990.x | eng |
hcfmusp.relation.reference | Tseng HF, 2003, CANCER CAUSE CONTROL, V14, P837, DOI 10.1023/B:CACO.0000003837.10664.7f | eng |
hcfmusp.relation.reference | van der Zee RP, 2013, NETH J MED, V71, P401 | eng |
hcfmusp.relation.reference | Vuitton L, 2018, CLIN GASTROENTEROL H, V16, P1768, DOI 10.1016/j.cgh.2018.03.008 | eng |
hcfmusp.relation.reference | Weinhardt LS, 1998, ARCH SEX BEHAV, V27, P155, DOI 10.1023/A:1018682530519 | eng |
hcfmusp.relation.reference | Wisniewski A, 2017, J CROHNS COLITIS, V11, P1011, DOI 10.1093/ecco-jcc/jjx035 | eng |
dc.description.index | MEDLINE | eng |
dc.identifier.eissn | 2164-554X | - |
hcfmusp.citation.scopus | 7 | - |
hcfmusp.scopus.lastupdate | 2024-03-29 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MDR Artigos e Materiais de Revistas Científicas - HC/ICESP Artigos e Materiais de Revistas Científicas - LIM/24 Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_NYITRAY_The_association_between_body_mass_index_and_anal_2019.PDF Restricted Access | publishedVersion (English) | 1.31 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.